Software Alternatives & Startups

Officially verified details Doctopass

Turn the consultation into a structured clinical note the doctor reviews and signs. Records, scheduling, prescriptions and billing in one AI-native platform.

Doctopass

Doctopass Reviews and Details

This page is designed to help you find out whether Doctopass is good and if it is the right choice for you.

Screenshots and images

  • Patient List //
    2026-09-04
  • Consultation //
    2026-09-04
  • ICD 10 //
    2026-09-04
  • Report //
    2026-09-04

Features & Specs

  1. AI clinical scribe

    Turns the consultation into a structured 8-section report. The doctor reviews and signs — the AI never signs.

  2. Patient records

    Full medical record with an 11-section history, documents and imaging.

  3. Scheduling

    Appointments, virtual waiting room, live visit status, SMS and WhatsApp reminders.

  4. E-prescribing

    National drug database with interaction and allergy checking.

  5. ICD-10 coding

    AI-suggested diagnostic codes. Suggestions only — the doctor decides.

  6. Insurance billing

    Act coding, invoicing with patient and insurer shares, claim statement generation. CNAM in Tunisia.

  7. Specialty modules

    Dedicated clinical tooling for 20 medical specialties.

  8. Role-based access

    Separate doctor, secretary and patient roles with granular permissions.

  9. Security

    Field-level encryption and audit logging. Registered with the INPDP.

  10. Languages

    French, Arabic and English.

Badges

Promote Doctopass. You can add any of these badges on your website.

SaaSHub badge
Show embed code

Questions & Answers

As answered by people managing Doctopass.
  1. What makes Doctopass unique?

    Doctopass is built for the Tunisian market rather than adapted to it. The AI scribe works in French and Arabic, and insurance billing follows the CNAM workflow: the act is entered at check-in, the invoice generates with the patient share, the insurer share and the CNAM code, and the claim statement is generated from it.

    The AI drafts; the doctor reviews and signs. The AI never signs a clinical note.

  2. Why should a person choose Doctopass over its competitors?

    Most practice software available in Tunisia is either installed locally, with patient data on the practitioner's own computer, or designed for another market and adapted afterwards.

    Doctopass is cloud-based with field-level encryption and audit logging, works on mobile as well as desktop, is trilingual French, Arabic and English, and handles CNAM billing natively. It is registered with the INPDP, Tunisia's data protection authority.

  3. How would you describe the primary audience of Doctopass?

    Solo practitioners and small to mid-sized medical practices in Tunisia, from a single doctor up to around 50 providers. Covers 20 specialties including cardiology, paediatrics, dentistry, ophthalmology and dermatology, with dedicated clinical tooling for each. Secretaries and patients have their own roles.

  4. Which are the primary technologies used for building Doctopass?

    Web application with native iOS, Android and desktop clients. Offline mode on desktop. Field-level encryption, audit logging, TOTP two-factor authentication. Interoperability through DICOM and HL7.

Videos

We don't have any videos for Doctopass yet.

Do you know an article comparing Doctopass to other products?
Suggest a link to a post with product alternatives.

Suggest an article

Doctopass discussion

Log in or Post with

Is Doctopass good? This is an informative page that will help you find out. Moreover, you can review and discuss Doctopass here. The primary details have been verified within the last quarter. So they could be considered up to date. If you think we are missing something, please use the means on this page to comment or suggest changes. All reviews and comments are highly encouranged and appreciated as they help everyone in the community to make an informed choice. Please always be kind and objective when evaluating a product and sharing your opinion.